Clinical trial · Interventional
The Effect of Foot Massage With Roles on Cancer Patients
Roles in the Management of Treatment-Induced Peripheral Neuropathy in Cancer Patients Receiving Taxane-Based Chemotherapy and the Effect of Foot Massage on Neuropathy and Quality of Life: A Randomized Controlled Study
NCT06376357CI-TRIAL-00076254unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It was aimed to examine the roles in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane-based chemotherapy and the effect of foot massage on neuropathy and quality of life.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Foot Massage | — | UNRESOLVED | — |
| Over Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Foot Massage with roller | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Study
- interventionNames
- Other: Foot Massage with roller
- type
- NO_INTERVENTION
- label
- Control
Primary outcomes (6)
- measure
- EORTC QLQ C-30 Quality of Life Scale
- timeFrame
- 10 minutes
- description
- Quality of life of patients will be evaluated with EORTC QLQ-C30, which was developed by EORTC for cancer patients and is widely used all over the world.
- measure
- CIPN20 Neuropathy Scale
- timeFrame
- 10 minutes
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Being registered in the medical oncology outpatient clinic of Selçuk University Faculty of Medicine Hospital * Completed standard taxane-based chemotherapy treatment protocol for breast and ovarian cancer * Karnofsky Performance Scale being 80 and above (Performance scale of cancer patients) * Being 18 years or older * Having received at least 3 cycles of taxane-based treatment * Presence of grade 2 or higher peripheral neuropathy * Being conscious and cooperative * Verbal and written approval to participate in the study after an explanation about the study is made. Exclusion Criteria: * Previous skin sensitivity on hands and feet * Refused to participate in the study after making a statement about the study * Development of peripheral neuropathy due to reasons other than chemotherapy \[tumor compression, nutritional disorders, infections or major systemic disease (diabetes mellitus, etc.)\] * Bone, spine metastasis or malignancy * Having mental and psychic problems that would prevent him from taking part in the research.
References
Publications (0)
Data not yet available
No reference posted for this study.